Intervention Study to Improve Life and Care for People With Dementia and Their Caregivers in Primary Care
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
|3||Active, not recruiting||
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
† Study has passed its completion date and status has not been verified in more than two years.